Intestinal uptake and transport of vitamin B12-loaded soy protein nanoparticles

Pharmaceutical Research

Volumn 32, Issue 4, 2015, Pages 1288-1303

  Zhang, Jing ^a   Field, Catherine J ^a   Vine, Donna ^a   Chen, Lingyun ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Caco 2 cells; intestinal transport; particle size; soy protein nanoparticles; vitamin B12

Indexed keywords

CYANOCOBALAMIN; NANOPARTICLE; SOYBEAN PROTEIN; SOYBEAN PROTEIN ISOLATE NANOPARTICLE; UNCLASSIFIED DRUG; DRUG CARRIER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CACO 2 CELL LINE; CELL COUNTING; CELL VIABILITY; CELLULAR DISTRIBUTION; COLORIMETRY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; INTESTINE ABSORPTION; MALE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PINOCYTOSIS; PRIORITY JOURNAL; RAT; SPECTROFLUOROMETRY; ZETA POTENTIAL; CHEMISTRY; CULTURE TECHNIQUE; DRUG EFFECTS; DRUG FORMULATION; FEASIBILITY STUDY; SURFACE PROPERTY; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL CULTURE TECHNIQUES; DRUG CARRIERS; DRUG COMPOUNDING; ENDOCYTOSIS; FEASIBILITY STUDIES; HUMANS; INTESTINAL ABSORPTION; NANOPARTICLES; PARTICLE SIZE; SOYBEAN PROTEINS; SURFACE PROPERTIES; VITAMIN B 12;

EID: 84925488585     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-014-1533-x     Document Type: Article

References (51)

1. 12 Absorption: mammalian physiology and acquired and inherited disorders. Biochimie. 2013;95:1002-7.
2. Allen RH, Seetharam B, Podell E, Alpers DH. Effect of proteolytic enzymes on the binding of cobalamin to r protein and intrinsic factor: in vitro evidence that a failure to partially degrade protein is responsible for cobalamin malabsorption in pancreatic insufficiency. J Clin Investig. 1978;61(1):47.
3. 12 intake with the factorial approach. Ann Nutr Metab. 2013;62(4):311-22.
4. 12 delivery. Anal Biochem. 2011;420(1):13-9.
5. Lin YH, Mi FL, Chen CT, Chang WC, Peng SF, Liang HF, et al. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules. 2007;8(1):146-52.
6. Lin YH, Chen CT, Liang HF, Kulkarni AR, Lee PW, Chen CH, et al. Novel nanoparticles for oral insulin delivery via the paracellular pathway. Nanotechnology. 2007;18(10):105102.
7. des Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 2006;116(1):1-27.
8. Livney YD. Milk proteins as vehicles for bioactives. Curr Opin Colloid Interface Sci. 2010;15(1):73-83.
9. Elzoghby AO, Samy WM, Elgindy NA. Protein-based nanocarriers as promising drug and gene delivery systems. J Control Release. 2012;161(1):38-49.
10. Teng Z, Luo YC, Wang Q. Nanoparticles synthesized from soy protein: preparation, characterization, and application for nutraceutical encapsulation. J Agric Food Chem. 2012;60(10):2712-20.
11. 3. Food Chem. 2013;141(1):524-32.
12. Teng Z, Luo Y, Wang T, Zhang B, Wang Q. Development and application of nanoparticles synthesized with folic acid conjugated soy protein. J Agric Food Chem. 2013;61(10):2556-64.
13. Zhang J, Liang L, Tian Z, Chen L, Subirade M. Preparation and in vitro evaluation of calcium-induced soy protein isolate nanoparticles and their formation mechanism study. Food Chem. 2012;133(2):390-9.
14. 12. J Phys Chem B. 2013;117(45):14018-28.
15. Lee KD, Nir S, Papahadjopoulos D. Quantitative analysis of liposome-cell interactions in vitro: rate constants of binding and endocytosis with suspension and adherent J774 cells and human monocytes. Biochemistry. 1993;32(3):889-99.
16. Borges O, Cordeiro-da-Silva A, Romeijn SG, Amidi M, de Sousa A, Borchard G, et al. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination. J Control Release. 2006;114(3):348-58.
17. Han J, Wang Q, Zhang Z, Gong T, Sun X. Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer. Small. 2013;10(3):524-35.
18. Yin Win K, Feng S-S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials. 2005;26(15):2713-22.
19. Beloqui A, Solinís MÁ, Gascón AR, del Pozo-Rodríguez A, des Rieux A, Préat V. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. J Control Release. 2013;166(2):115-23.
20. Déat-Lainé E, Hoffart V, Garrait G, Beyssac E. Whey protein and alginate hydrogel microparticles for insulin intestinal absorption: evaluation of permeability enhancement properties on Caco-2 cells. Int J Pharm. 2012;453(2):336-42.
21. 12 using a co-culture process with lactobacillus plantarum SM39 and propionibacterium freudenreichii DF13. Process Biochem. 2011;46(5):1063-70.
22. Vine D, Charman S, Gibson P, Sinclair A, Porter C. Effect of dietary fatty acids on the intestinal permeability of marker drug compounds in excised rat jejunum. J Pharm Pharmacol. 2002;54(6):809-19.
23. Institute of Medicine. Food and Nutrition Board. Dietary reference intakes: thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academy Press; 1998.
24. Akbari B, Tavandashti MP, Zandrahimi M. Particle size characterization of nanoparticles-a practical approach. Iran J Mater Sci Eng. 2011;8(2):48-56.
25. Pan X, Yu S, Yao P, Shao Z. Self-assembly of β-casein and lysozyme. J Colloid Interface Sci. 2007;316(2):405-12.
26. Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology. 1989;96(3):736-49.
27. He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31(13):3657-66.
28. Yin Win K, Feng SS. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials. 2005;26(15):2713-22.
29. Liu Y, Wang P, Sun C, Feng N, Zhou W, Yang Y, et al. Wheat germ agglutinin-grafted lipid nanoparticles: preparation and in vitro evaluation of the association with Caco-2 monolayers. Int J Pharm. 2010;397(1):155-63.
30. Jiang L, Li X, Liu L, Zhang Q. Cellular uptake mechanism and intracellular fate of hydrophobically modified pullulan nanoparticles. Int J Nanomedicine. 2013;8:1825.
31. Catizone A, Medolago Albani L, Reola F, Alescio T. A quantitative assessment of non-specific pinocytosis by human endothelial cells surviving in vitro. Cell Mol Biol. 1993;39(2):155-69.
32. Panyam J, Dali MM, Sahoo SK, Ma W, Chakravarthi SS, Amidon GL, et al. Polymer degradation and in vitro release of a model protein from poly (d, l-lactide-co-glycolide) nano-and microparticles. J Control Release. 2003;92(1):173-87.
33. 4 nanoparticles. J Mater Chem. 2009;19(35):6328-31.
34. Behrens I, Pena AIV, Alonso MJ, Kissel T. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Pharm Res. 2002;19(8):1185-93.
35. Lu W, Zhang Y, Tan YZ, Hu KL, Jiang XG, Fu SK. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J Control Release. 2005;107(3):428-48.
36. del Pozo-Rodriguez A, Pujals S, Delgado D, Solinís M, Gascón A, Giralt E, et al. A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors. J Control Release. 2009;133(1):52-9.
37. Bareford LM, Swaan PW. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev. 2007;59(8):748-58.
38. He CB, Hu YP, Yin LC, Tang C, Yin CH. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31(13):3657-66.
39. Harley VS, Dance DA, Drasar BS, Tovey G. Effects of burkholderia pseudomallei and other burkholderia species on eukaryotic cells in tissue culture. Microbios. 1997;96(384):71-93.
40. Luo Y, Teng Z, Wang TT, Wang Q. Cellular uptake and transport of zein nanoparticles: effects of sodium caseinate. J Agric Food Chem. 2013;61(31):7621-9.
41. Lin IC, Liang MT, Liu TY, Ziora ZM, Monteiro MJ, Toth I. Interaction of densely polymer-coated gold nanoparticles with epithelial Caco-2 monolayers. Biomacromolecules. 2011;12(4):1339-48.
42. Rieux A, Ragnarsson EG, Gullberg E, Préat V, Schneider YJ, Artursson P. Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. Eur J Pharm Sci. 2005;25(4):455-65.
43. Rieux A, Ragnarsson EG, Gullberg E, Préat V, Schneider YJ, Artursson P. Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. Eur J Pharm Sci. 2005;25(4):455-65.
44. Jung T, Kamm W, Breitenbach A, Kaiserling E, Xiao J, Kissel T. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur J Pharm Biopharm. 2000;50(1):147-60.
45. Delie F, Rubas W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit Rev Ther Drug Carrier Syst 1997;14(3)
46. Deitch E. Nutrition and the gut mucosal barrier. Curr Opin Gen Surg. 1992:85-91
47. Gaumet M, Gurny R, Delie F. Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size. Eur J Pharm Sci. 2009;36(4):465-73.
48. Pappenheimer JR. Physiological regulation of transepithelial impedance in the intestinal mucosa of rats and hamsters. J Membr Biol. 1987;100(1):137-48.
49. Verma A, Uzun O, Hu Y, Hu Y, Han HS, Watson N, et al. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater. 2008;7(7):588-95.
50. Jiang M, Gan L, Zhu C, Dong Y, Liu J, Gan Y. Cationic core-shell liponanoparticles for ocular gene delivery. Biomaterials. 2012;33(30):7621-30.
51. 12 deficiency in spinal cord injury. Arch Phys Med Rehabil. 2003;84(11):1675-9.